QuidelOrtho Price to Free Cash Flow Ratio 2010-2024 | QDEL
Historical price to free cash flow ratio values for QuidelOrtho (QDEL) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| QuidelOrtho Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-12-30 | 44.00 | 0.00 | |
| 2024-09-30 | 45.60 | $-1.43 | 0.00 |
| 2024-06-30 | 33.22 | $-2.53 | 0.00 |
| 2024-03-31 | 47.94 | $-1.77 | 0.00 |
| 2023-12-31 | 73.70 | $1.06 | 69.44 |
| 2023-09-30 | 73.04 | $4.12 | 17.73 |
| 2023-06-30 | 82.86 | $0.79 | 105.34 |
| 2023-03-31 | 89.09 | $3.52 | 25.33 |
| 2022-12-31 | 85.67 | $12.97 | 6.61 |
| 2022-09-30 | 71.48 | $16.12 | 4.43 |
| 2022-06-30 | 97.18 | $18.77 | 5.18 |
| 2022-03-31 | 112.46 | $11.59 | 9.70 |
| 2021-12-31 | 134.99 | $11.96 | 11.29 |
| 2021-09-30 | 141.15 | $14.68 | 9.61 |
| 2021-06-30 | 128.12 | $16.50 | 7.76 |
| 2021-03-31 | 127.93 | $23.33 | 5.48 |
| 2020-12-31 | 179.65 | $12.95 | 13.87 |
| 2020-09-30 | 219.38 | $4.46 | 49.22 |
| 2020-06-30 | 223.74 | $3.44 | 65.02 |
| 2020-03-31 | 97.81 | $3.11 | 31.43 |
| 2019-12-31 | 75.03 | $2.49 | 30.16 |
| 2019-09-30 | 61.35 | $2.40 | 25.60 |
| 2019-06-30 | 59.32 | $2.65 | 22.40 |
| 2019-03-31 | 65.47 | $-1.12 | 0.00 |
| 2018-12-31 | 48.82 | $2.46 | 19.85 |
| 2018-09-30 | 65.17 | $1.83 | 35.60 |
| 2018-06-30 | 66.50 | $1.13 | 59.08 |
| 2018-03-31 | 51.81 | $3.77 | 13.73 |
| 2017-12-31 | 43.35 | $0.30 | 143.40 |
| 2017-09-30 | 43.86 | $0.49 | 88.71 |
| 2017-06-30 | 27.14 | $0.72 | 37.96 |
| 2017-03-31 | 22.64 | $1.05 | 21.54 |
| 2016-12-31 | 21.42 | $-0.00 | 0.00 |
| 2016-09-30 | 22.09 | $-0.05 | 0.00 |
| 2016-06-30 | 17.86 | $-0.12 | 0.00 |
| 2016-03-31 | 17.26 | $-0.52 | 0.00 |
| 2015-12-31 | 21.20 | $0.58 | 36.43 |
| 2015-09-30 | 18.88 | $0.69 | 27.21 |
| 2015-06-30 | 22.95 | $0.86 | 26.72 |
| 2015-03-31 | 26.98 | $0.99 | 27.36 |
| 2014-12-31 | 28.92 | $0.71 | 40.76 |
| 2014-09-30 | 26.87 | $0.19 | 144.85 |
| 2014-06-30 | 22.11 | $-0.07 | 0.00 |
| 2014-03-31 | 27.30 | $-0.24 | 0.00 |
| 2013-12-31 | 30.89 | $0.14 | 222.07 |
| 2013-09-30 | 28.40 | $0.47 | 61.06 |
| 2013-06-30 | 25.53 | $0.70 | 36.30 |
| 2013-03-31 | 23.75 | $1.06 | 22.49 |
| 2012-12-31 | 18.67 | $0.22 | 83.53 |
| 2012-09-30 | 18.93 | $0.31 | 60.33 |
| 2012-06-30 | 15.68 | $0.35 | 44.70 |
| 2012-03-31 | 18.37 | $0.60 | 30.72 |
| 2011-12-31 | 15.13 | $1.28 | 11.81 |
| 2011-09-30 | 16.37 | $1.02 | 16.06 |
| 2011-06-30 | 15.15 | $0.96 | 15.74 |
| 2011-03-31 | 11.96 | $0.71 | 16.90 |
| 2010-12-31 | 14.45 | $-0.58 | 0.00 |
| 2010-09-30 | 10.99 | $0.70 | 15.76 |
| 2010-06-30 | 12.69 | $1.26 | 10.10 |
| 2010-03-31 | 14.54 | $1.36 | 10.67 |
| 2009-12-31 | 13.78 | $2.18 | 6.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.000B | $2.998B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.931B | 25.50 |
| Stryker (SYK) | United States | $140.829B | 31.74 |
| Boston Scientific (BSX) | United States | $134.782B | 38.75 |
| EssilorLuxottica (ESLOY) | France | $111.024B | 0.00 |
| Medtronic (MDT) | Ireland | $104.635B | 15.54 |
| Haleon (HLN) | United Kingdom | $44.090B | 28.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.326B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.417B | 18.89 |
| ResMed (RMD) | United States | $34.333B | 28.21 |
| Terumo (TRUMY) | Japan | $28.994B | 40.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.222B | 18.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.351B | 13.59 |
| Insulet (PODD) | United States | $18.636B | 74.21 |
| Baxter (BAX) | United States | $14.960B | 9.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.694B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.888B | 39.78 |
| Bio-Rad Laboratories (BIO) | United States | $9.278B | 31.53 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.483B | 15.06 |
| Haemonetics (HAE) | United States | $3.960B | 19.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.914B | 19.47 |
| ICU Medical (ICUI) | United States | $3.831B | 36.47 |
| Perrigo (PRGO) | Ireland | $3.548B | 10.45 |
| Envista Holdings (NVST) | United States | $3.328B | 24.80 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.779B | 17.82 |
| Neogen (NEOG) | United States | $2.694B | 31.08 |
| LeMaitre Vascular (LMAT) | United States | $2.114B | 51.39 |
| Green Thumb Industries (GTBIF) | United States | $1.638B | 28.67 |
| AtriCure (ATRC) | United States | $1.499B | 0.00 |
| InMode (INMD) | Israel | $1.453B | 8.74 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.417B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.41 |
| BioLife Solutions (BLFS) | United States | $1.254B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.014B | 0.00 |
| Owens & Minor (OMI) | United States | $1.000B | 7.81 |
| CeriBell (CBLL) | United States | $0.949B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.878B | 15.49 |
| Evolus (EOLS) | United States | $0.719B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.640B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.621B | 27.40 |
| Omeros (OMER) | United States | $0.606B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.425B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| ZimVie (ZIMV) | United States | $0.389B | 32.81 |
| Valneva SE (VALN) | France | $0.341B | 0.00 |
| Biote (BTMD) | United States | $0.335B | 7.35 |
| Viemed Healthcare (VMD) | United States | $0.318B | 30.26 |
| Canopy Growth (CGC) | Canada | $0.309B | 0.00 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.299B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.265B | 55.47 |
| High Tide (HITI) | Canada | $0.259B | 107.33 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.209B | 14.42 |
| MacroGenics (MGNX) | United States | $0.205B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.194B | 2.73 |
| Jin Medical (ZJYL) | China | $0.186B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.184B | 0.00 |
| Brainsway (BWAY) | Israel | $0.176B | 93.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.58 |
| Quipt Home Medical (QIPT) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 10.93 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Safety Shot (SHOT) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.81 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |